Patients on tegoprubart reported fewer transplant-related symptoms and better quality of life at 12 months than those on ...

Facing steep 2027 cost increases, employers are narrowing obesity drug coverage, while direct-to-employer models let them cap ...

Karin Johnson, MD, says permanent daylight saving time won’t boost exercise or road safety and that sleep loss from spring ...

Cleveland Clinic's Beth Faiman, PhD, MSN, says fast-moving myeloma care requires funded education and fewer barriers for ...

Nikhil C. Munshi, MD, says 25% to 30% of patients with myeloma may now be cured, but relapse and access remain challenges.

Mayo Clinic case-control study links higher birth weight and childhood obesity to greater non-Hodgkin lymphoma risk, while ...

Participating insurers reduced prior authorization requirements by 11% overall, equating to approximately 6.5 million fewer requests, with Medicare Advantage experiencing a greater than 15% reduction.

Kidney Week 2026 brought strong IgAN data, looked back on 5 years of value-based kidney care, and highlighted evidence of ...

T2D-2, retatrutide lowered A1C 2.2 points vs 1.8 with semaglutide 2 mg and more than doubled weight loss at 80 weeks.

Home-based oncology transforms practice transformation with clear bagging, protecting Medicare reimbursement, provider ...

AI in myeloproliferative neoplasms can grade marrow fibrosis and predict survival, but authors say prospective, ...

PBM reform, Medicare Advantage exits, and the 340B rebate pilot are reshaping drug access. Here is what payers need to know ...